Advertisement

You are subscribed to the FormularyWatch.

Formulary

eNewsletter Subscribe

April 15, 2015

Web Version  | Share with a colleague

Facebook Like Twitter Tweet

Today's Headlines

Cancer drug prices vary widely depending on who's paying

Patients without insurance could be asked to pay twice as much or more than insurers pay for chemotherapy, according to a study published in he April issue of Health Affairs. » Variation details

Combination BP meds raise risk of mortality in elderly

Researchers raised concerns about the safety of prescribing combination antihypertensive medications in elderly patients with low blood pressure, in new study. » A cautionary note

Continuing Education

2015 Updates on the national guidelines for diabetes management and related disorders

Last month and this month pharmacists will be able to learn about the latest developments in diabetes treatment and management. Pharmacists can earn up to 4 hours of CPE credit with two monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics. The goal of this month's activity is to discuss the recent updates of national U.S. guidelines for diabetes management, including hypertension and cholesterol management in patients with diabetes, in order to empower pharmacists in clinical decision-making.

Read/print the article: Click here

Take the test: Click here to log in with the Session Code 15DT16-TAJ88.


Announcement: Our CE activities have moved to a new learning management system to better serve you. The login to the Online CE Center is https://web2.uconn.edu/pharmacyce/login.php. All current user registration information has been uploaded for your convenience. Current users do not need to register. To review your registration page to ensure the data is up to date or to register, go to https://web2.uconn.edu/pharmacyce/program_register.php. For a full list of courses, go to http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/

EDITOR'S PICK

FDA actions

FDA approvals, fast-track designations, priority reviews, breakthrough therapies, orphan drugs. » Read more

 

RELATED ARTICLES

Specialty drug coverage varies across health plans

Cholesterol-lowering agent leads list of most-prescribed drugs

RESOURCES

Latest Clinical News

Powered by Modern Medicine Advanstar Medical Communications Group